Donanemab for Alzheimer Disease-Who Benefits and Who Is Harmed? Manly JJ, Deters KD. JAMA 2023 Jul 17. doi: 10.1001/jama.2023.11704.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Manly JJ, Deters KD. Donanemab for Alzheimer Disease-Who Benefits and Who Is Harmed? JAMA 2023 Jul 17. doi: 10.1001/jama.2023.11704.
PMID: 37459138